Bill > HR6897

This bill, known as the Thyroid Disease CARE Act of 2025, aims to improve the understanding and treatment of thyroid disease by advancing research, promoting public awareness, and enhancing healthcare. The Secretary of Health and Human Services (HHS) will lead these efforts, which include supporting research into the causes, diagnosis, and treatment of thyroid disease, with a specific focus on thyroid cancer and its impact on women of reproductive age. The bill also mandates an analysis of research gaps and disproportionate impacts of thyroid disease on various populations, disaggregated by race, ethnicity, geography, and other demographic factors, to identify reasons for disparities in care and knowledge among healthcare professionals. Furthermore, it calls for a public awareness campaign to educate individuals about thyroid disease signs and symptoms, treatment options, and the potential benefits of routine screening, especially during pregnancy. The Secretary will collaborate with professional societies and relevant agencies within HHS to implement these provisions, with authorized appropriations of $30 million annually for research and analysis, and $3 million annually for the public awareness campaign, for fiscal years 2026 through 2030.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/6897/all-info